(Q57392733)

English

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis

article by Jaya Chakravarty et al published April 2011 in Vaccine

In more languages

Statements

scholarly article

0 references

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis (English)

0 references

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Karen D Cowgill

object named as

Karen D. Cowgill

11

0 references

13

object named as

Shyam Sundar

0 references

12

object named as

Steven G. Reed

0 references

8

object named as

Rhea N. Coler

0 references

author name string

Jaya Chakravarty

1

0 references

Subodh Kumar

2

0 references

Sonali Trivedi

3

0 references

Vijay K. Rai

4

0 references

Anup Singh

5

0 references

Jill A. Ashman

6

0 references

Elsa M. Laughlin

7

0 references

Stuart J. Kahn

9

0 references

Anna Marie Beckmann

10

0 references

Franco M. Piazza

14

0 references

language of work or name

0 references

publication date

April 2011

0 references

0 references

29

0 references

19

0 references

3531-3537

0 references

Leishmaniasis and poverty

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Leishmaniasis: current situation and new perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

The burden of visceral leishmaniasis in South Asia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Leishmaniasis: current treatment and prospects for new drugs and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

The economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Household cost-of-illness of visceral leishmaniasis in Bihar, India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Management of visceral leishmaniasis in rural primary health care services in Bihar, India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Taking toll: lipid A mimetics as adjuvants and immunomodulators

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Development of a leishmaniasis vaccine: the importance of MPL.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

The epidemiology of Leishmania donovani infection in high transmission foci in India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Risk factors for kala-azar in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Immunity in kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Visceral leishmaniasis: new health tools are needed

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.02.096

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.02.096

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57392733&oldid=1997543844"